Drawing for TIL

USPTO serial 90618141

TIL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
POLZER, NATALIE M
Law office
TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard Y. Kim

Richard Y. Kim Snell & Wilmer L.L.P.400 East Van Buren Street, Suite 1900One Arizona CenterPhoenix, AZ 85004-2202

Goods and services

ClassDescriptionStatusFirst use
005cells; cell growth and or stimulatory factors; white blood cell or lymphocyte growth and or stimulatory factors; white blood cells or lymphocytes; medicaments and or therapies and or treatments containing cells and or white blood cells or lymphocytes; reagents for tissue digestion and or cell isolation and or cell storage and or cell population expansion or amplification and or cell growth and or cell stimulation; reagents for solid tumor tissue digestion and or white blood cell or lymphocyte isolation and or cell storage and or white blood cell or lymphocyte population expansion or amplification and or white blood cell or lymphocyte growth and or stimulationACTIVE—
010medical apparatus for collection of solid biological tissue samples or specimens, or for collection of solid biological tumor tissue samples, and or isolation of cells therefrom or isolation and storage of cells therefrom, or isolation of white blood cells or lymphocytes therefrom, or isolation and storage of white blood cells therefromACTIVE—
039providing services and or biomedical services and or methods for tissue digestion and or cell isolation and or cell storage and or cell population expansion or amplification and or cell growth or stimulation and or solid tumor tissue digestion and or white blood cell or lymphocyte isolation and or white blood cell or lymphocyte storage and or white blood cell or lymphocyte expansion or amplification and or white blood cell or lymphocyte growth or stimulation; providing services and or and or biomedical services and or methods for treating patients having a tumor or solid tumorACTIVE—
042research and development in the fields of: tissue digestion; tumor tissue digestion; cell isolation, storage and or expansion or amplification; white blood cell or lymphocyte isolation, storage and or expansion or amplification; reagents for cell population expansion or amplification; reagents for expansion or amplification of white blood cells or lymphocytes; cell growth and or stimulatory factors; white blood cell or lymphocyte growth and or stimulatory factors; tumors; white blood cells; lymphocytes; medical apparatus for: collection of solid biological tissue samples or specimens, or for collection of solid biological tumor tissue samples, and or isolation of cells therefrom or isolation and storage of cells therefrom, or isolation of white blood cells or lymphocytes therefrom, or isolation and storage of white blood cells therefromACTIVE—
044providing a website featuring information in the field of the diagnosis and treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 10, 2022MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 10, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 27, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2021DOCKASSIGNED TO EXAMINER—
Jul 9, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 5, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance